Navigation Links
Reportlinker Adds Product Profiles: Multiple Sclerosis - Gilenya Raises Bar for New Market Entrants
Date:6/27/2011

rologists prescribe Gilenya because of its strong efficacy in treatment resistant patients as well as its convenient oral mode of administration. However, long term cancer and infection risk remain the main concerns.

The multiple sclerosis market has been lucrative for drug companies over the last decade with limited competition and periodic price increases. However, as this dynamic is changing with increased competition, existing players are expanding their portfolios with new and improved therapies.

Monoclonal antibodies have demonstrated potent efficacy in Phase II trials, surpassing all existing therapies. However, excitement is tempered with safety concerns that include risk of malignancy and severe infections. Still, as seen with Tysabri, impressive efficacy may outweigh the risks for more severe multiple sclerosis patients.

Your key questions answered

* How well do agents in late-stage development for multiple sclerosis compare to one another and the current standard of care?

* What is the most promising treatment in development for multiple sclerosis?

* How do US neurologists perceive Gilenya and key pipeline agents as new treatments of multiple sclerosis?

Executive Summary

Strategic scoping and focus

Datamonitor key findings

Related reports

OVERVIEW

Catalyst

Summary

MARKET OVERVIEW

Product overview

Datamonitor's assessment summary

MARKETED PRODUCT PROFILES

Gilenya (fingolimod; Novartis/Mitsubishi Tanabe Pharma)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Physician perception of Gilenya

Clinical and commercial attractiveness

Avonex (interferon beta-1a; Biogen Idec)

Drug profile

Development overview

SWOT analysis

Satisfaction of unmet needs

Product positioning

Clinical and commerci
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... Care Management (CCM) and Drug Adherence m Health ... help automate the process of non face-to-face monitoring ... "With this new release of our apps, doctors ... management services along with our ONCHIT certified Physician, ...
(Date:9/1/2015)... , Sept. 1, 2015 Within ... employees, SHL Group has rapidly reached 3,000 employees ... rapid growth in the injectable drug delivery market ... A global leader in the design and ... offers innovative designs, robust manufacturing capabilities, a lean ...
(Date:9/1/2015)... , Sept. 1, 2015 Egalet Corporation ... specialty pharmaceutical company focused on discovering, developing, and ... will be  presenting scientific data on SPRIX ® ... extended-release, oral morphine product candidate, and Egalet-002, an ... PainWeek 2015 to be held September ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2SHL Group Reaches Major Milestone of 3000 Employees 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6
... /PRNewswire-Asia-FirstCall/ -- Sinovac Biotech Ltd. (Nasdaq: SVA ... announced today its preliminary unaudited sales range for the ... guidance for full year 2010. A conference call to ... be held on October 25, 2010 at 8:00 a.m. ...
... The National Community Pharmacists Association (NCPA) today announced ... President and CEO, heralding her as an ideal ... and lead it to new heights as an ... and the patients they serve. (Logo: ...
Cached Medicine Technology:Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 2Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 3Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations 4NCPA Announces Kathleen Jaeger as CEO 2
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Self-Directed Care is, how to access caregivers and what to look for and ... and pertinent information. , Founded in 2006 in Canoga Park, CA by CEO, ...
(Date:9/1/2015)... ... September 01, 2015 , ... The integration ... patients directly from Practice Perfect to FOTO enabling cost and time savings, reducing ... , Steven Presement, President of Practice Perfect, stated "FOTO is a natural extension ...
(Date:9/1/2015)... ... ... Routines… every family has them. Whether it’s a morning routine, meal time routine ... children too. Here are three reasons why routines can be beneficial for a child: ... routine is implemented into a child’s schedule, they are able to anticipate what will ...
(Date:9/1/2015)... ... September 01, 2015 , ... Specialty Technical Publishers (STP) and ... Protocol Consortium (IAPC) EHS audit protocol for the European Union. Leading companies around ... EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an organized ... physical therapy patients. The Registry is being developed by the American Physical Therapy Association ... happy to be selected to contribute FOTO Outcomes measures as one of the primary ...
Breaking Medicine News(10 mins):Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... Reserve University researchers, from the School of Medicine,s Department ... products of lipid peroxidation and some drugs of abuse, ... by a combination of metabolomics and mass isotopomer analysis. ... action of the drug of abuse gamma-hydroxybutyrate, also known ...
... ... looking for an alternative to the high price of dental work in the US, Canada, and ... Vacation is a great choice as a dental tourist destination. , ... (PRWEB) December 4, 2009 -- After being in business for more than ...
... Move a response to pressure from federal regulators to crack ... (HealthDay News) -- The makers of 24 different prescription painkillers ... abuse of these opioid drugs. , The pharmaceutical companies ... officials to find a way to stop the hundreds of ...
... for at-risk patient groups , FRIDAY, Dec. 4 (HealthDay ... central nervous system tumors, carry the risk of late ... analyzed data from 12,795 five-year survivors of the most ... Cancer Survivor Study. , The researchers found that the ...
... shows , FRIDAY, Dec. 4 (HealthDay News) -- Water pipes ... , A new study found that people who smoke tobacco ... puts them at risk for heart disease and nicotine addiction. ... who smoked tobacco using a water pipe and a single ...
... ... ... inventor garnering national attention with an invention proven to help individuals lose weight, prevent ... Saturday’s Technology Fair located at the Civic Center Gallery., , , , , TrekDesk ...
Cached Medicine News:Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2
Inquire...
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: